Urine bombesin-like peptide elevation precedes clinical evidence of bronchopulmonary dysplasia

American Journal of Respiratory and Critical Care Medicine

Volumn 165, Issue 8, 2002, Pages 1093-1097

  Cullen, Anne ^a,b   Van Marter, Linda J ^a,b   Allred, Elizabeth N ^a,b   Moore, Marianne ^a,b   Parad, Richard B ^a,b   Sunday, Mary E ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Lung injury; Mechanical ventilation; Prematurity; Pulmonary neuroendocrine cells

Indexed keywords

BOMBESIN DERIVATIVE; BOMBESIN LIKE PEPTIDE; CREATININE; OXYGEN; UNCLASSIFIED DRUG;

ARTICLE; BAROTRAUMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOREACTIVITY; LOW BIRTH WEIGHT; LUNG DYSPLASIA; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; NEUROSECRETORY CELL; NEWBORN; NEWBORN SCREENING; OXYGEN THERAPY; PREDICTION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RADIOIMMUNOASSAY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; URINALYSIS;

EID: 0037090632     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.165.8.2108044     Document Type: Article

References (36)

1. Pulmonary disease following respirator therapy of hyaline membrane disease
2. Chronic lung disease
3. Chronic lung disease: Bronchopulmonary dysplasia
4. Mechanisms initiating lung injury in the preterm
5. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers
6. Bronchopulmonary dysplasia: Twenty-five years later
7. Improved survival accounts for most, but not all of the increase in bronchopulmonary dysplasia
8. Beneficial effects of the combined use of prenatal corticosteroids and postnatal surfactant on preterm infants
9. Late pulmonary outcomes poorly predicted by early risk factors in very low birth weight infants
10. Bioactive peptides and lung development
11. Pulmonary neuroendocrine cells in hyaline membrane disease and bronchopulmonary dysplasia
12. A baboon model of bronchopulmonary dysplasia: II. Pathologic features
13. Neonatal chronic lung disease in extremely immature baboons
14. Bombesin-like peptide mediates lung injury in a baboon model of bronchopulmonary dysplasia
15. Stability of bombesin in serum, plasma, urine, and culture media
16. Increased serum and urinary calcitonin levels in patients with pulmonary disease
17. Plasma GRP-like immunoreactivity in healthy and diseased subjects
18. Urinary levels of bombesin-like peptides in asymptomatic cigarette smokers: A potential risk marker for smoking-related diseases
19. Urinary bombesin-like peptide levels in infants and children with bronchopulmonary dysplasia and cystic fibrosis
20. Bombesin and [leu8]phyllolitorin promote fetal mouse lung branching morphogenesis via a receptor-mediated mechanism
21. Biology of disease: Gastrin-releasing peptide (mammalian bombesin) gene expression in health and disease
22. The bronchoconstrictor action of the tetradecapeptide bombesin in the guinea-pig
23. Modulation of phagocytic function in murine peritoneal macrophages by bombesin, gastrin-releasing peptide and neuromedin C
24. Bombesin enhances monocyte and macrophage activities: Possible role in the modulation of local pulmonary defenses in chronic bronchitis
25. Migration of 3T3 and lung fibroblasts in response to calcitonin gene-related peptide and bombesin
26. Evidence from twin study implies possible genetic susceptibility to bronchopulmonary dysplasia
27. Associations between family history of asthma, bronchopulmonary dysplasia, and childhood asthma in very low birth weight children
28. Family history of asthma in infants with bronchopulmonary dysplasia
29. Neuropeptides and lung development
30. Intrapulmonary neuro-epithelial bodies in newborn rabbits. Influence of hypoxia, hyperoxia, hypercapnia, nicotine, reserpine, L-DOPA and 5-HTP
31. CGRP-immunoreactive endocrine cell proliferation in normal and hypoxic rat lung studied by immunocytochemical detection of incorporation of 5′-bromodeoxyuridine
32. Tumor necrosis factor induces neuroendocrine differentiation in small cell lung carcinoma cell lines
33. Modulation of oncogene and tumor suppressor gene expression in a hamster model of chronic lung injury with varying degrees of pulmonary neuroendocrine cell hyperplasia
34. Treatment of fetal baboons with a SOD mimetic in a model of bronchopulmonary dysplasia
35. The diffuse neuroendocrine system and the APUD concept: Related "endocrine" peptides in brain, intestine, pituitary, placenta, and anuran cutaneous glands